P. McGrath

发表

Is there an association among low untreated serum lipid levels, anger, and hazardous driving?

K. Davidson, D. Zitner, K. W. Davidson, 1996, International journal of behavioral medicine.

Increases in depression after cholesterol-lowering drug treatment.

D. Zitner, K. W. Davidson, S. Reddy, 1996, Behavioral medicine.

Imipramine treatment of alcoholism with comorbid depression.

P. McGrath, E. Nunes, W. Harrison, 1993, The American journal of psychiatry.

Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

D. Kupfer, B. Lebowitz, M. Fava, 2006 .

Current concepts in the treatment of depression in alcohol-dependent patients.

P. McGrath, E. Nunes, F. Quitkin, 2000, The Psychiatric clinics of North America.

Atypical depression. A valid clinical entity?

P J McGrath, J. Rabkin, J. Stewart, 1993, The Psychiatric clinics of North America.

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

D. Kupfer, B. Lebowitz, M. Fava, 2004, Controlled clinical trials.

Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.

Bradley N Gaynes, Maurizio Fava, Philip W Lavori, 2009, The American journal of psychiatry.

Chronic depression: response to placebo, imipramine, and phenelzine.

J. Rabkin, J. Stewart, P. McGrath, 1993, Journal of clinical psychopharmacology.

Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.

D. Klein, M. Liebowitz, J. Rabkin, 1988, The American journal of psychiatry.

Antidepressant specificity in atypical depression.

D. Klein, M. Liebowitz, J. Rabkin, 1988, Archives of general psychiatry.

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.

D. Klein, J. Rabkin, J. Stewart, 1989, Archives of general psychiatry.

The timing of phototherapy: effects on clinical response and the melatonin cycle.

J. Stewart, P. McGrath, F. Quitkin, 1987, Psychopharmacology bulletin.

Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.

M. Fava, A. Rush, M. Trivedi, 2008, The Journal of clinical psychiatry.

Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

David J. Kupfer, Philip W. Lavori, Madhukar H. Trivedi, 2008 .

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

M. Fava, A. Rush, M. Trivedi, 2006, The American journal of psychiatry.

Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.

J. Stewart, P. McGrath, W. Harrison, 1989, Archives of general psychiatry.

Response of the melatonin cycle to phototherapy for Seasonal Affective Disorder

F. Quitkin, J. M. German, P. McGrath, 2005, Journal of Neural Transmission.

Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression.

P J McGrath, J. Amsterdam, F. Quitkin, 2000, The Journal of clinical psychiatry.

Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission.

J. Stewart, P. McGrath, F. Quitkin, 1997, The American journal of psychiatry.

A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.

J. Stewart, P. McGrath, F. Quitkin, 1994, The International journal of eating disorders.

Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.

J. Stewart, P. McGrath, W. Harrison, 1987, Psychopharmacology bulletin.